Both in Pharmaceuticals
Sarepta Therapeutics, vs First Tracks Biotherapeutics
Over the past year SRPT returned −6.8% and TRAX returned +32.3%; their daily moves had a correlation of 0.70.
SRPT −6.8% TRAX +32.3%Growth of $1, one year, split-adjusted
| Metric | SRPT | TRAX |
|---|---|---|
| Price | $19.06 | $48.21 |
| Market cap | $2.01B | $2.03B |
| Today | +2.80% | +4.04% |
| 1 month | +10.1% | +53.6% |
| 6 months | −17.2% | — |
| Year to date | −11.4% | — |
| 1 year | −22.0% | — |
| Revenue growth (YoY) | −34.3% | — |
| Gross margin | 62.8% | — |
| Net margin | −1.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | -$59.1M | $168.0M |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | — |
| Short % of float | 22.7% | 21.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).